New Study: Asbestos Exposure on Commercial Ships
A new study Inhalation Toxicology looks at the health risks of asbestos exposure on commercial ships. Read more at Mesothelioma Cancer Alliance.
Tag: Mesothelioma News
Sydney Bridge Asbestos Stokes Concerns
Workers on a famous bridge in Sydney unexpectedly found asbestos under concrete slabs earlier this year, and some government officials are questioning why they didn’t find out for nearly 10 months. A crew on the Sydney Harbour Bridge, which carries vehicular traffic, a rail line and pedestrian and cycling lanes over Sydney Harbour, reportedly discovered the asbestos while removing a toll booth in February 2016.
Treatments to prolong life for mesothelioma patients closer
The scientists at Adelaide’s Flinders University have found that malignant mesothelioma tumours are able to transform into blood vessels, promoting their own growth. “Instead of waiting for the outside of the tissue to grow blood vessels in, the tumour cells themselves branch out, growing blood vessels that reach out into surrounding tissues, tapping into the native vasculature,” she said.
Devastated widow’s appeal for answers after husband dies of asbestos-related cancer
Liz Burke is appealing for help to trace her late husband John’s former colleagues after he died from mesothelioma in December last year The heartbroken widow of a former labourer has issued a desperate plea for answers after his death from asbestos-related cancer. John Burke, from Hamsterley Colliery, County Durham , was diagnosed with mesothelioma, a terminal cancer caused by exposure to asbestos, in September 2015 after suffering with pain in his chest and breathlessness.
MKSAP: 57-year-old man with a right-sided pleural effusion
A 57-year-old man is evaluated in follow-up for a right-sided pleural effusion. He initially presented with increasing dyspnea and a constant dull ache on his right side.
Aduro Biotech Highlights Positive Clinical Results from Second Cohort …
Aduro Biotech, Inc. today announced highlights from a poster presentation at the Annual Meeting of the Society for Immunotherapy of Cancer being held in National Harbor, Maryland on the preliminary safety and efficacy of its novel immunotherapy, CRS-20…
Asbestos Discovered During Stratford Highway Project
The Connecticut State Department of Transportation has announced that asbestos was discovered during the Exit 33 highway construction.
Asbestos Discovered During Stratford Highway Project
The Connecticut State Department of Transportation has announced that asbestos was discovered during the Exit 33 highway construction.
Tecentriq Raises Hope of New Mesothelioma Clinical Trial
The FDA recently approved immunotherapy drug Tecentriq (atezolizumab) for certain bladder and non-small cell lung cancers, raising hopes for a mesothelioma-specific clinical trial in 2017. Tecentriq, a product of Genentech Oncology, is following the path of Keytruda (pembrolizumab) and Opdivo (nivolumab) as drugs that target a specific protein blocking a body’s immune system from attacking…
The post Tecentriq Raises Hope of New Mesothelioma Clinical Trial appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.
Mesothelioma Compensation Center Now Urges Utility Workers with Mesothelioma to Not Take Big…
The Mesothelioma Compensation Center says, “We are urging a person with mesothelioma who had exposure to asbestos at a public utility, water/sewer district, or any type of power generating facility to call us anytime at 866-714-6466 to make certain they get a lawyer upgrade to pursue a mesothelioma compensation claim. Please do not take the ‘big bucks’ advertising baloney on the Internet or cable TV seriously.
Ptac2S Potentially More Effective Than Cisplatin When Fighting Mesothelioma
Malignant Pleural Mesothelioma (MPM) is a rare, aggressive asbestos –related cancer that has a poor survival rate due to the fact that the cancer is hard to detect early, and once detected, has usually spread and is hard to control. Surgery is typically an effective option for removing cancerous cells, but in some cases, surgery
Ptac2S Potentially More Effective Than Cisplatin When Fighting Mesothelioma
Malignant Pleural Mesothelioma (MPM) is a rare, aggressive asbestos –related cancer that has a poor survival rate due to the fact that the cancer is hard to detect early, and once detected, has usually spread and is hard to control. Surgery is typically an effective option for removing cancerous cells, but in some cases, surgery
New Zealand Asbestos Guide Aims to Reduce Deaths
New Zealand has a new guide for managing and removing asbestos in the workplace. The “Approved Code of Practice for the Management and Removal of Asbestos,” or ACOP, was designed to complement the Health and Safety at Work (Asbestos) Regulations 2016. Described as the first for the country, the new guide hopes to cut asbestos-related…
The post New Zealand Asbestos Guide Aims to Reduce Deaths appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.
Atezolizumab Approved for Non-Small Cell Lung Cancer Patients
PD-L1 inhibitor atezolizumab has been approved for use with chemotherapy-refractory metastatic Non-Small Cell Lung Cancer patients.
Atezolizumab Approved for Non-Small Cell Lung Cancer Patients
PD-L1 inhibitor atezolizumab has been approved for use with chemotherapy-refractory metastatic Non-Small Cell Lung Cancer patients.